Treating Heart Failure With Enhanced External Counterpulsation (EECP): Design of the Prospective Evaluation of EECP in Heart Failure (PEECH) Trial
Enhanced external counterpulsation (EECP) treatment can improve exercise tolerance in patients with ischemic heart disease; however, the possible benefits of EECP in patients with stable heart failure (HF) and left ventricular dysfunction (LVD) are unclear.
Surgical Trauma Affects the Proinflammatory Status After Cardiac Surgery to a Higher Degree Than Cardiopulmonary Bypass
To quantify the contribution of bypass-induced versus trauma-induced inflammatory response after coronary artery bypass grafting, we examined plasma cytokine levels in 120 patients with coronary artery disease who were treated with or without cardiopulmonary bypass-assisted procedures.
Activation of Neutrophils and Monocytes by a Leukocyte-Depleting Filter Used Throughout Cardiopulmonary Bypass
We studied the effects of a leukocyte-depleting filter on phagocyte activation during cardiopulmonary bypass.
Activation of Neutrophils and Monocytes by a Leukocyte-Depleting Filter Used Throughout Cardiopulmonary Bypass
We studied the effects of a leukocyte-depleting filter on phagocyte activation during cardiopulmonary bypass.
Activation of Neutrophils and Monocytes by a Leukocyte-Depleting Filter Used Throughout Cardiopulmonary Bypass
We studied the effects of a leukocyte-depleting filter on phagocyte activation during cardiopulmonary bypass.
Large Bolus Dose vs. Continuous Infusion of Cisatracurium During Hypothermic Cardiopulmonary Bypass Surgery
We investigated whether a high bolus dose of cisatracurium (8x ED95) given at induction can provide muscle relaxation for the major part of a cardiac procedure with hypothermic cardiopulmonary bypass, avoid important postoperative residual curarization and cause no waste of product.
Large Bolus Dose vs. Continuous Infusion of Cisatracurium During Hypothermic Cardiopulmonary Bypass Surgery
We investigated whether a high bolus dose of cisatracurium (8x ED95) given at induction can provide muscle relaxation for the major part of a cardiac procedure with hypothermic cardiopulmonary bypass, avoid important postoperative residual curarization and cause no waste of product.
Large Bolus Dose vs. Continuous Infusion of Cisatracurium During Hypothermic Cardiopulmonary Bypass Surgery
We investigated whether a high bolus dose of cisatracurium (8x ED95) given at induction can provide muscle relaxation for the major part of a cardiac procedure with hypothermic cardiopulmonary bypass, avoid important postoperative residual curarization and cause no waste of product.
Feasibility of Continuous CO2 Removal With Hydrophilic Membranes at Low Blood Flow Rates
It is concluded that CO2 removal from slowly flowing blood with hydrophilic membranes is feasible.
Rat Cardiopulmonary Bypass Model: Application of a Miniature Extracorporeal Circuit Composed of Asanguinous Prime
A clinically relevant rat cardiopulmonary bypass (CPB) model would be a valuable tool for investigating pathophysiological and therapeutic strategies on bypass.
Clinical Evaluation of Poly(2-Methoxyethylacrylate) in Primary Coronary Artery Bypass Grafting
Poly(2-methoxyethylacrylate) (PMEA, X-coating) is a new polymer coating used in the ECC.
Rat Cardiopulmonary Bypass Model: Application of a Miniature Extracorporeal Circuit Composed of Asanguinous Prime
A clinically relevant rat cardiopulmonary bypass (CPB) model would be a valuable tool for investigating pathophysiological and therapeutic strategies on bypass.